Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer

Background: Centrosomal Protein 55 (CEP55) was initially described as a main participant in the final stage of cytokinesis. Further research identified CEP55 as a cancer-testis antigen (CTA) that is aberrantly expressed in different malignancies and a cancer vaccination candidate. The current study...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xiaodong, Liang, Hongyin, Jiangting, Wushuang, Wang, Yu, Ma, Xiao, Tan, Zhen, Cheng, Long, Luo, Zhulin, Wang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360201/
https://www.ncbi.nlm.nih.gov/pubmed/37484531
http://dx.doi.org/10.3389/fmolb.2023.1198557

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360201/
https://www.ncbi.nlm.nih.gov/pubmed/37484531
http://dx.doi.org/10.3389/fmolb.2023.1198557

Ejemplares similares